Table 3 Univariate and multivariate regression analyses to determine predictors of MSK discomfort among the study HD patients (n = 94)

Gender

 Male

Ref

-

-

-

 Female

3.960

1.338–11.720

0.013*

-

-

-

Clinical characteristics

 Hypertension

7.700

2.576–23.012

 < 0.001*

-

-

-

Therapeutic data

 Erythropoitin

8.821

3.143–24.758

 < 0.001*

5.655

1.368–23.374

0.017*

 Calcium supplementation

3.878

1.438–10.457

 < 0.007*

-

-

-

 Iron supplementation

4.20

1.419–12.429

0.010*

-

-

-

 Antihypertensives

6.565

2.043–21.095

0.002*

-

-

-

Pain and symptom burden

 Pain

1.429

1.165–1.753

0.001*

1.312

1.013–1.699

0.040*

 Fatigue

1.304

1.059–1.605

0.012*

-

-

-

 Depressed

1.302

1.055–1.606

0.014*

-

-

-

 Anxiety

1.378

1.110–1.712

0.004*

-

-

-

 Drowsiness

1.282

1.040–1.579

0.020*

Multidimensional Fatigue Inventory

 Reduced activity

1.307

1.027–1.663

0.029*

-

-

-

Pittsburgh Sleep Quality Index

 Subjective sleep quality

2.023

1.095–3.737

0.025*

-

-

-

 Daytime dysfunction

1.741

1.002–3.023

0.049*

-

-

-

 Global PSQI score

1.178

1.019–1.362

0.027*

-

-

-